December 18, 2007 - Cardiovascular disease (CVD) death rates are declining, but CVD is still the No. 1 cause of death in the U.S. and risk factor control remains a challenge for many, according to the most recent data from the American Heart Association’s Heart Disease and Stroke Statistics - 2008 Update, which was released today.

December 17, 2007 - Boston Scientific Corp. and Avista Capital Partners announced that Avista will acquire Boston Scientific’s Fluid Management and Venous Access businesses for $425 million in cash as part of Boston Scientific’s plan to divest non-strategic assets.

The transaction is expected to close in the first quarter of 2008, subject to regulatory approvals and customary conditions.

December 17, 2007 - Bristol-Myers Squibb Co. said Monday it has signed an agreement to sell its medical imaging unit to Avista Capital Partner for approximately $525 million.

The unit, Billerica, MA-based Bristol-Myers Squibb Medical Imaging, is a supplier of medical imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures.

December 17, 2007 - Medtronic Inc. today announced it received FDA clearance of the Reveal DX and Reveal XT, new insertable cardiac monitors (ICMs) designed to provide diagnostic and monitoring insights to cardiologists managing their patients with syncope (fainting) or abnormal heart rhythms, including ventricular tachyarrhythmias (VT), fast ventricular tachyarrhythmias (FVT), bradyarrhythmias and asystole.

December 17, 2007 - ProSolv CardioVascular, a Fujifilm Company, announced today that KLAS ranked it number one in the KLAS 2007 Cardiology PACS Study, which it received by achieving the highest total score when evaluated on 40 performance indicators, ranking first in 26 of the 40 indicators.

December 17, 2007 - Patients treated with drug-eluting stents must take a combination of aspirin and the clot-reducing drug clopidogrel for at least one year, and possibly longer, after stent implantation, according to a guideline update published online today in the journals of the Society for Cardiovascular Angiography and Interventions (SCAI), American College of cardiology (ACC) and American Heart Association (AHA).

December 17, 2007 – Medtronic today announced it received Japanese regulatory approval on December 10, 2007 for the Sprint Quattro (Model 6944 and 6947) steroid-eluting right ventricular lead used with implantable cardioverter-defibrillators (ICDs) that detect and treat rapid heart rhythms, representing Japan’s first 8.6 French defibrillation lead to feature screw-in fixation.

FUJIFILM Medical Systems USA Inc. is the only DR vendor to offer facilities the choice of two similar but unique DR detectors, both of which provide the highest resolution and fastest image availability of any available DR system, according to the manufacturer.

December 14, 2007 - According to a guideline update published online today in the journals of the Society for Cardiovascular Angiography and Interventions (SCAI), American College of Cardiology (ACC) and American Heart Association (AHA), patients treated with drug-eluting stents must take a combination of aspirin and the clot-reducing drug clopidogrel for at least one year, and possibly longer, after stent implantation.

December 14, 2007 - Boston Scientific Corp. has agreed to sell its Fluid Management and Venous Access businesses to Avista Capital Partners for $425 million in cash; the transaction is expected to close in the first quarter of 2008, subject to regulatory approvals and customary conditions

Avista said that upon close of the transaction, the combined Fluid Management/Venous Access business would operate as an independent company under a new name.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now